Portfolio company
Imvitro
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Imvitro develops an artificial intelligence platform for embryo selection to help fertility clinics improve success rates and transparency for IVF patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Fairtility
Fairtility develops artificial intelligence software for embryo assessment and clinical decision support to help fertility clinics and embryologists improve outcomes.
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
Vitra Labs
The company develops a stem cell platform to produce eggs for patients undergoing fertility treatments without the use of hormones or donor tissue.
FemTech
This company provides artificial intelligence-powered fertility treatments and clinical care for patients experiencing infertility.
Fertilia AI
This company develops a data platform that centralises fertility treatment records and appointment notes to support couples navigating reproductive healthcare journeys.
Onto
This company provides an AI-driven clinical platform delivering physician-led fertility and reproductive care services to individuals and couples.
Genomic Prediction
The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.
Reticular
This company develops interpretable artificial intelligence models for embryo genetic screening and drug discovery to assist prospective parents and pharmaceutical researchers.
